Corrigendum to "Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice"

BioMed Research International
Marc GotkineHanna Rosenmann

Abstract

[This corrects the article DOI: 10.1155/2013/845345.].

Methods Mentioned

BETA
Antisense Oligonucleotides

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Related Papers

Medicare & Medicaid Research Review
United European Gastroenterology Journal
BioMed Research International
Ahmet ErogluOzgun Cuvas Apan
International Journal of Pediatrics
Erin M MacdonaldM Karen Campbell
© 2021 Meta ULC. All rights reserved